From the OPTIMA (A.V., A.D.S., H.R.), Department of Pharmacology, University of Oxford, Oxford, UK; Department of Surveillance and Evaluation (E.N.), National Institute for Health Development, Tallinn, Estonia; Institute of Basic Medical Sciences (A.V., E.N., C.A.D., H.R.), Department of Nutrition, Faculty of Medicine, University of Oslo, Oslo; Section for Pharmacology (P.M.U.), Institute of Medicine, University of Bergen and Haukeland Hospital, Bergen; Department of Public Health and Primary Health Care (S.E.V., H.A.N., G.S.T.), University of Bergen, Bergen; NKS Olaviken Hospital for Old Age Psychiatry (H.A.N.), Erdal; and Norwegian Center for Dementia Research (K.E.), Department of Geriatric Medicine, Ullevål University Hospital, Oslo, Norway.
Address correspondence and reprint requests to Anna Vogiatzoglou, DPhil, Department of Food and Nutritional Sciences, University of Reading, Whiteknights, PO Box 226, Reading RG6 6AP, UK. E-mail: [email protected]
This project was supported by the Norwegian Foundation for Health and Rehabilitation through the Norwegian Health Association, the Johan Throne Holst Foundation for Nutrition Research, the Alzheimer’s Research Trust (UK), the Charles Wolfson Charitable Trust (UK), the Advanced Research Program of Norway, the Research Council of Norway, and The Foundation to promote research into functional vitamin B12 deficiency.
The authors declare no conflict of interest.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.psychosomaticmedicine.org).
Received for publication March 30, 2011; revision received September 7, 2012.
